Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve | NEJM
![PDF] Rivaroxaban versus Warfarin in Patients with Mechanical Heart Valve: Rationale and Design of the RIWA Study | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b848b4c36977bfee20ba4b3ed5bd220554206359/3-Figure1-1.png "PDF] Rivaroxaban versus Warfarin in Patients with Mechanical Heart Valve: Rationale and Design of the RIWA Study | Semantic Scholar")
PDF] Rivaroxaban versus Warfarin in Patients with Mechanical Heart Valve: Rationale and Design of the RIWA Study | Semantic Scholar
A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: Rationale and design of the RIVER trial - ScienceDirect
Rivaroxaban is Comparable to Warfarin for Bioprosthetic Mitral Valves and AF | DAIC
Rivaroxaban and Dabigatran for Suppression of Mechanical Heart Valve–Induced Thrombin Generation - The Annals of Thoracic Surgery
A controlled trial of rivaroxaban after transcatheter aortic-valve replacement (GALILEO)
Home - ICHP KeePosted
Rivaroxaban and Dabigatran for Suppression of Mechanical Heart Valve–Induced Thrombin Generation - The Annals of Thoracic Surgery
Rivaroxaban in patients with mechanical heart valves: A pilot study - Thrombosis Research
PDF) Rivaroxaban Versus Warfarin in Patients with Mechanical Heart Valves: Open-Label, Proof-of-Concept trial—The RIWA study
Comparison of Adherence to Rivaroxaban Versus Apixaban Among Patients With Atrial Fibrillation - ScienceDirect
PDF) Mechanical Valve Thrombosis on Rivaroxaban: Are Novel Anticoagulants Really an Option?
PLOS ONE: Adherence to rivaroxaban versus apixaban among patients with non-valvular atrial fibrillation: Analysis of overall population and subgroups of prior oral anticoagulant users
2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation - Chao - 2021 - Journal of Arrhythmia - Wiley Online Library
PDF) Initial experience with rivaroxaban in mechanical valve prosthesis in an animal model
RIVERtrial - Twitter Search / Twitter
หนอนน้อยอ่านเปเปอร์ - Contraindications to the Use of Non–Vitamin K Oral Anticoagulants (ตามรูป) o Valvular atrial fibrillation (prosthetic valve, rheumatic mitral valvular disease, prior mitral valve repair) o Mechanical prosthetic heart valve o
Antithrombotic Therapy in Patients With Valvular Heart Disease
Rivaroxaban and Dabigatran for Suppression of Mechanical Heart Valve–Induced Thrombin Generation - The Annals of Thoracic Surgery
VisualAbstract: Rivaroxaban noninferior to warfarin in patients with atrial fibrillation and bioprosthetic mitral valves | 2 Minute Medicine
Xarelto Full Prescribing Information, Dosage & Side Effects | MIMS Hong Kong
Rivaroxaban and Dabigatran for Suppression of Mechanical Heart Valve–Induced Thrombin Generation - The Annals of Thoracic Surgery
Comparison of the Efficacy and Safety of Direct Oral Anticoagulants and Warfarin After Bioprosthetic Valve Replacements | Semantic Scholar
Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve | NEJM
